← back to search

Matthias Dottermusch

Universität Hamburg · DE
Area of research
Genetics · Molecular Biology
Research interest
Research interests include Glioma Diagnosis and Treatment, Pituitary Gland Disorders and Treatments, Chromatin Remodeling and Cancer, and Epigenetics and DNA Methylation.
h-index
15
citations
2,020
works
58
NIH funding
primary concept
email

Recent publications

Extracellular Vesicles Carrying Tenascin-C are Clinical Biomarkers and Improve Tumor-Derived DNA Analysis in Glioblastoma Patients
ACS Nano 2025cited by 19position: middledoi
Investigation of a global mouse methylome atlas reveals subtype-specific copy number alterations in pediatric cancer models
Nature Genetics 2025cited by 2position: middledoi
Pituitary neuroendocrine tumors with PIT1/SF1 co-expression show distinct clinicopathological and molecular features
Acta Neuropathologica 2024cited by 38position: firstdoi
Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level
Nature Communications 2024cited by 19position: middledoi
Integrated analyses reveal two molecularly and clinically distinct subtypes of H3 K27M-mutant diffuse midline gliomas with prognostic significance
Acta Neuropathologica 2024cited by 15position: middledoi
Morphology‐based molecular classification of spinal cord ependymomas using deep neural networks
Brain Pathology 2024cited by 8position: middledoi
Single-cell transcriptomics link gene expression signatures to clinicopathological features of gonadotroph and lactotroph PitNET
Journal of Translational Medicine 2024cited by 3position: middledoi
METB-03. SOLID PEDIATRIC TUMORS IN MICE REVEAL MODEL-SPECIFIC GLOBAL DNA METHYLATION AND CNV PROFILES CORRESPONDING TO HUMAN COUNTERPARTS
Neuro-Oncology 2024cited by 0position: middledoi
Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entities
Neuro-Oncology 2023cited by 22position: middledoi
Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signatures
Nature Communications 2023cited by 16position: middledoi
Metastases to the pituitary gland: insights from the German pituitary tumor registry
Pituitary 2023cited by 2position: middledoi
Low‐grade diffusely infiltrative tumour (LGDIT), SMARCB1‐mutant: A clinical and histopathological distinct entity showing epigenetic similarity with ATRT‐MYC
Neuropathology and Applied Neurobiology 2022cited by 8position: middledoi
Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup
Brain Pathology 2021cited by 40position: middledoi
Co-activation of Sonic hedgehog and Wnt signaling in murine retinal precursor cells drives ocular lesions with features of intraocular medulloepithelioma
Oncogenesis 2021cited by 0position: firstdoi
Neuropathology of patients with COVID-19 in Germany: a post-mortem case series
The Lancet Neurology 2020cited by 1,348position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Julia E. Neumann · Universität Hamburg7 papers (2021–2025)Ulrich Schüller · Universität Hamburg7 papers (2021–2024)Markus Glatzel · Universität Hamburg4 papers (2020–2024)Christian Thomas · University of Münster3 papers (2021–2024)Leonille Schweizer · Goethe University Frankfurt3 papers (2021–2024)Simone Schmid · German Cancer Research Center3 papers (2023–2024)Annika K. Wefers · University Hospital Regensburg2 papers (2023–2024) · 2 papers (2023–2024) · 2 papers (2023–2024)Christian Hagel · Universität Hamburg2 papers (2020–2023)Wolfgang Saeger · Universität Hamburg2 papers (2023–2024)Martin Hasselblatt · University Hospital Münster2 papers (2021–2022) · 2 papers (2023–2024)Michael C. Frühwald · Bayer (Germany)2 papers (2021–2022)Werner Paulus · Université de Montpellier2 papers (2021–2022)Stephan Frank · University of Basel2 papers (2021–2024)Pascal D. Johann · Bayer (Germany)2 papers (2021–2022)Marcel Kool · European Bioinformatics Institute2 papers (2021–2022)Franz Ricklefs · Universität Hamburg2 papers (2024–2025) · 2 papers (2021–2022)